The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sickle Cell-Global Market Insights and Sales Trends 2024
Synopsis
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
The global Sickle Cell market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sickle Cell in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Sickle Cell market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sickle Cell, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sickle Cell market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sickle Cell market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sickle Cell sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sickle Cell covered in this report include Novartis, Bristol-Myers Squibb, Takeda, Bluebird Bio and Global Blood Therapeutics, etc.
The global Sickle Cell market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
Global Sickle Cell market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sickle Cell market, Segment by Type:
Diagnosis
Treatment
Global Sickle Cell market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sickle Cell companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
The global Sickle Cell market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sickle Cell in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Sickle Cell market. Diagnosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment segment is estimated at % CAGR for the next seven-year period.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sickle Cell, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sickle Cell market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sickle Cell market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sickle Cell sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sickle Cell covered in this report include Novartis, Bristol-Myers Squibb, Takeda, Bluebird Bio and Global Blood Therapeutics, etc.
The global Sickle Cell market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
Global Sickle Cell market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sickle Cell market, Segment by Type:
Diagnosis
Treatment
Global Sickle Cell market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sickle Cell companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sickle Cell
1.1 Sickle Cell Market Overview
1.1.1 Sickle Cell Product Scope
1.1.2 Sickle Cell Market Status and Outlook
1.2 Global Sickle Cell Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sickle Cell Market Size by Region (2018-2029)
1.4 Global Sickle Cell Historic Market Size by Region (2018-2023)
1.5 Global Sickle Cell Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sickle Cell Market Size (2018-2029)
1.6.1 North America Sickle Cell Market Size (2018-2029)
1.6.2 Europe Sickle Cell Market Size (2018-2029)
1.6.3 Asia-Pacific Sickle Cell Market Size (2018-2029)
1.6.4 Latin America Sickle Cell Market Size (2018-2029)
1.6.5 Middle East & Africa Sickle Cell Market Size (2018-2029)
2 Sickle Cell Market by Type
2.1 Introduction
2.1.1 Diagnosis
2.1.2 Treatment
2.2 Global Sickle Cell Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sickle Cell Historic Market Size by Type (2018-2023)
2.2.2 Global Sickle Cell Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sickle Cell Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sickle Cell Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sickle Cell Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sickle Cell Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sickle Cell Revenue Breakdown by Type (2018-2029)
3 Sickle Cell Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Sickle Cell Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sickle Cell Historic Market Size by Application (2018-2023)
3.2.2 Global Sickle Cell Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sickle Cell Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sickle Cell Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sickle Cell Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sickle Cell Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sickle Cell Revenue Breakdown by Application (2018-2029)
4 Sickle Cell Competition Analysis by Players
4.1 Global Sickle Cell Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sickle Cell as of 2022)
4.3 Date of Key Players Enter into Sickle Cell Market
4.4 Global Top Players Sickle Cell Headquarters and Area Served
4.5 Key Players Sickle Cell Product Solution and Service
4.6 Competitive Status
4.6.1 Sickle Cell Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Sickle Cell Products, Services and Solutions
5.1.4 Novartis Sickle Cell Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Profile
5.2.2 Bristol-Myers Squibb Main Business
5.2.3 Bristol-Myers Squibb Sickle Cell Products, Services and Solutions
5.2.4 Bristol-Myers Squibb Sickle Cell Revenue (US$ Million) & (2018-2023)
5.2.5 Bristol-Myers Squibb Recent Developments
5.3 Takeda
5.3.1 Takeda Profile
5.3.2 Takeda Main Business
5.3.3 Takeda Sickle Cell Products, Services and Solutions
5.3.4 Takeda Sickle Cell Revenue (US$ Million) & (2018-2023)
5.3.5 Bluebird Bio Recent Developments
5.4 Bluebird Bio
5.4.1 Bluebird Bio Profile
5.4.2 Bluebird Bio Main Business
5.4.3 Bluebird Bio Sickle Cell Products, Services and Solutions
5.4.4 Bluebird Bio Sickle Cell Revenue (US$ Million) & (2018-2023)
5.4.5 Bluebird Bio Recent Developments
5.5 Global Blood Therapeutics
5.5.1 Global Blood Therapeutics Profile
5.5.2 Global Blood Therapeutics Main Business
5.5.3 Global Blood Therapeutics Sickle Cell Products, Services and Solutions
5.5.4 Global Blood Therapeutics Sickle Cell Revenue (US$ Million) & (2018-2023)
5.5.5 Global Blood Therapeutics Recent Developments
6 North America
6.1 North America Sickle Cell Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sickle Cell Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sickle Cell Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sickle Cell Market Dynamics
11.1 Sickle Cell Industry Trends
11.2 Sickle Cell Market Drivers
11.3 Sickle Cell Market Challenges
11.4 Sickle Cell Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
